We Offer Worldwide Shipping
Login Wishlist

Methylparaben

$43

  • Brand : BIOFRON

  • Catalogue Number : BF-M3010

  • Specification : 98%

  • CAS number : 99-76-3

  • Formula : C8H8O3

  • Molecular Weight : 152.15

  • PUBCHEM ID : 7456

  • Volume : 100mg

In stock

Quantity
Checkout Bulk Order?

Catalogue Number

BF-M3010

Analysis Method

HPLC,NMR,MS

Specification

98%

Storage

2-8°C

Molecular Weight

152.15

Appearance

White crystalline powder

Botanical Source

barks of Tsuga dumosa

Structure Type

Phenolics

Category

Standards;Natural Pytochemical;API

SMILES

COC(=O)C1=CC=C(C=C1)O

Synonyms

methyl p-hydroxybenzoate/4-Hydroxybenzoic acid, methyl ester/4-(Carbomethoxy)phenol/Mekkings M/Benzoic acid, 4-hydroxy-, methyl ester/Methylparaben/4-(Methoxycarbonyl)phenol/Methyl parahydroxybenzoate/Killitol/Methyl chemosept/Methyl-4-hydroxybenzoate/p-Hydroxybenzoic acid methyl ester/methyl para-hydroxybenzoate/4-Hydroxybenzoic Acid Methyl Ester/Methyl 4-hydroxybenzoate/Benzoic acid, p-hydroxy-, methyl ester/Nipagin/4-Hydroxy-benzoic acid methyl ester/Metagin/p-Hydroxybenzoic acid, methyl ester/p-Hydroxybenzoic methyl ester/Methyl parasept/Tegosept M/4-Hydroxybenzoic acid methylester/Methyl Paraben

IUPAC Name

methyl 4-hydroxybenzoate

Applications

Methyl Paraben, isolated from the barks of Tsuga dumosa the methyl ester of p-hydroxybenzoic acid, is a standardized chemical allergen. Methyl Paraben is a stable, non-volatile compound used as an antimicrobial preservative in foods, drugs and cosmetics. The physiologic effect of Methyl Paraben is by means of increased histamine release, and cell-mediated immunity[1].

Density

1.2±0.1 g/cm3

Solubility

Methanol; DMSO

Flash Point

116.4±12.6 °C

Boiling Point

265.5±13.0 °C at 760 mmHg

Melting Point

125-128 °C(lit.)

InChl

InChl Key

WGK Germany

RID/ADR

HS Code Reference

2918290000

Personal Projective Equipment

Correct Usage

For Reference Standard and R&D, Not for Human Use Directly.

Meta Tag

provides coniferyl ferulate(CAS#:99-76-3) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of coniferyl ferulate are included as well.>> amp version: coniferyl ferulate

PMID

28428009

Abstract

In this study, the toxicity of methylparaben (MeP) an emerging contaminant, was analysed in the sexual species Artemia franciscana, due to its presence in coastal areas and marine saltworks in the Mediterranean region. The acute toxicity (24h-LC50) of MeP in nauplii was tested and its chronic effect (9days) evaluated by measuring survival and growth under two sublethal concentrations (0.0085 and 0.017mg/L). Also, the effect on several key enzymes involved in: antioxidant defences (catalase (CAT) and gluthathion-S-transferase (GST)), neural activity (cholinesterase (ChE)) and xenobiotic biotransformation (carboxylesterase (CbE), was assessed after 48h under sublethal exposure. The results of acute exposure indicate that MeP is harmful to A. franciscana (24h-LC50=36.7mg/L). MeP causes a decrease in CAT activity after 48h exposure to both concentration tested, that points out at the oxidative stress effect of MeP in A. franciscana. However, no significant effect on ChE, CbE and GST activities was found. In addition, MeP does not affect survival and growth in chronic exposure at the sublethal concentrations tested. The results of this study indicate that MeP is not a threat for A. franciscana under the experimental conditions used. Additional studies should be done considering long-term exposure and reproduction studies to analyse the potential risk of MeP as emerging contaminant in marine and hypersaline environments.

Published by Elsevier Inc.

KEYWORDS

Aquaculture; Artemia franciscana; Biodiversity; Biomarkers; Methylparaben; Toxicity

Title

Effect of methylparaben in Artemia franciscana.

Author

Comeche A1, Martin-Villamil M2, Pico Y3, Varo I4.

Publish date

2017 Sep

PMID

30392093

Abstract

Since the 1930s, parabens have been employed widely as preservatives in food, pharmaceutical, and personal care products. These alkyl esters of benzoic acid occur naturally in a broad range of plant species, where they are thought to enhance overall fitness through disease resistance and allelopathy. Current manufacture of parabens relies on chemical synthesis and the processing of 4-hydroxybenzoate as a precursor. A variety of bio-based production platforms have targeted 4-hydroxybenzoate for a greener alternative to chemical manufacturing, but parabens have yet to be made in microbes. Here, we deploy the plant enzyme benzoic acid carboxyl methyltransferase together with four additional recombinant enzymes to produce methylparaben in Escherichia coli. The feasibility of a tyrosine-dependent route to methylparaben is explored, establishing a framework for linking paraben production to emerging high-tyrosine E. coli strains. However, our use of a unique plant enzyme for bio-based methylparaben biosynthesis is potentially applicable to any microbial system engineered for the manufacture of 4-hydroxybenzoate.

KEYWORDS

Benzoic acid carboxyl methyltransferase (BSMT); Escherichia coli; Methylparaben; Plant enzyme; Tyrosine-dependent biosynthesis

Title

Production of methylparaben in Escherichia coli.

Author

Hagel JM1, Chen X1, Facchini PJ2.

Publish date

2019 Jan

PMID

32283359

Abstract

BACKGROUND:
Parabens, which are used as a preservative in foods and personal care products, are detected in nearly 100% of human urine samples. Exposure to parabens is associated with DNA damage, male infertility, and endocrine disruption in adults, but the effects of prenatal exposure are unclear. In part, this is due to inadequate assessment of exposure in maternal urine, which may only reflect maternal rather than fetal exposure. To address this gap, we examined the association of prenatal methylparaben measured in meconium with preterm birth, gestational age, birthweight, maternal thyroid hormones, and child Attention-Deficit Hyperactivity Disorder (ADHD) at 6-7 years.

DESIGN:
Data come from the GESTation and the Environment (GESTE) prospective observational pregnancy cohort in Sherbrooke, Quebec, Canada. Participants were 345 children with data on ADHD among 394 eligible pregnancies in women age ≥18 years with no known thyroid disease before pregnancy and meconium collected at delivery. Methylparaben was measured in meconium. Birthweight, gestational age, and maternal thyroid hormones at <20 weeks gestation were measured at the Centre Hospitalier Universitaire de Sherbrooke. Preterm birth was defined as vaginal birth before the 37th week of gestation. Physician diagnosis of ADHD was determined at a scheduled cohort follow-up when children were 6-7 years old or from medical records. Associations between meconium methylparaben and outcomes were estimated with logistic and linear regressions weighted on the inverse probability of exposure to account for potential confounders, including child sex, familial income, maternal education, pre-pregnancy body mass index, age, and smoking and alcohol consumption during pregnancy.

RESULTS:
Methylparaben was detected in 65 meconium samples (19%), 33 children were diagnosed with ADHD (10%), and 13 children were born preterm (4%). Meconium methylparaben was associated with preterm birth (odds ratio [OR] = 4.81; 95% CI [2.29, 10.10]), decreased gestational age (beta [β] = -0.61 weeks; 95% CI [-0.93, -0.29]) and birthweight (β = -0.12 kg; 95% CI [-0.21, -0.03]), altered maternal TSH (relative concentration [RC] = 0.76; 95% CI [0.58, 0.99]), total T3 (RC = 0.84; 95% CI [0.75, 0.96]) and total T4 (RC = 1.10; 95% CI [1.01, 1.19]), maternal hypothyroxinemia (OR = 2.50, 95% CI [1.01, 6.22]), and child ADHD at age of 6-7 (OR = 2.33, 95% CI [1.45, 3.76]). The effect of meconium methylparaben on ADHD was partially mediated by preterm birth (20% mediation) and birthweight (13% mediation).

CONCLUSIONS:
Meconium methylparaben was associated with preterm birth, decreased gestational age and birthweight, maternal thyroid hormone dysfunction, and child ADHD. Parabens are a substantial health concern if causally related to these adverse outcomes.

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

KEYWORDS

Attention-Deficit Hyperactivity Disorder (ADHD); Birth outcomes; Endocrine disruption; Parabens; Prenatal exposure; Thyroid hormones

Title

Methylparaben in meconium and risk of maternal thyroid dysfunction, adverse birth outcomes, and Attention-Deficit Hyperactivity Disorder (ADHD).

Author

Baker BH1, Wu H2, Laue HE3, Boivin A4, Gillet V4, Langlois MF5, Bellenger JP6, Baccarelli AA2, Takser L4.

Publish date

2020 Apr 10